7825.TWO

The company maintains a strong liquidity position, with cash and equivalents amounting to TWD 133.97 billion, which is 41% of total assets. However, the liquidity risk is rated as medium due to the negative net cash position after subtracting total debt of TWD 135.15 billion. The price-to-book ratio of 6.71 and price-to-tangible-book ratio of 6.71 suggest the market is valuing the company significantly above its book value, indicating potential overvaluation or high growth expectations. Profitability metrics show a return on equity (ROE) of 14.76% and return on assets (ROA) of 8.36%, both exceeding the typical thresholds for the integrated hardware and software industry. The operating margin of 19.2% (calculated from operating income of TWD 75.72 billion on revenue of TWD 394.5 billion) is also robust, suggesting efficient cost management and pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes, particularly in its primary market. No specific geographic breakdown is provided in the available data. The company's revenue growth is expected to remain stable, with no significant changes in the current fiscal year or the next. Historical revenue of TWD 394.5 billion reflects a strong performance, but the outlook does not indicate a clear upward or downward trajectory. The capital expenditure of TWD -10.08 billion suggests a reduction in investment, which may signal a focus on cost control or a shift in strategic priorities. The risk assessment highlights a medium liquidity risk and a low dilution risk. The negative net cash position is a key flag, indicating potential pressure to raise additional capital or manage debt obligations. No dilution sources are identified in the available data, and the dilution risk is assessed as low. Recent events include the latest financial filing, which provides a comprehensive overview of the company's financial health. No significant events or transcripts are disclosed in the available data that would suggest a material change in the company's operations or strategy.